ALPS Advisors’s Arbutus Biopharma ABUS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q2 | – | Sell |
-107,107
| Closed | -$325K | – | 995 |
|
|
2023
Q1 | $325K | Buy |
107,107
+877
| +0.8% | +$2.66K | ﹤0.01% | 781 |
|
|
2022
Q4 | $248K | Buy |
106,230
+24,352
| +30% | +$56.7K | ﹤0.01% | 966 |
|
|
2022
Q3 | $156K | Sell |
81,878
-6,346
| -7% | -$12.1K | ﹤0.01% | 1019 |
|
|
2022
Q2 | $239K | Sell |
88,224
-64,538
| -42% | -$175K | ﹤0.01% | 961 |
|
|
2022
Q1 | $455K | Sell |
152,762
-3,784
| -2% | -$11.3K | ﹤0.01% | 444 |
|
|
2021
Q4 | $609K | Buy |
+156,546
| New | +$609K | 0.01% | 465 |
|
|
2019
Q2 | – | Sell |
-134,053
| Closed | -$480K | – | 878 |
|
|
2019
Q1 | $480K | Buy |
134,053
+6,016
| +5% | +$21.5K | ﹤0.01% | 535 |
|
|
2018
Q4 | $490K | Buy |
+128,037
| New | +$490K | ﹤0.01% | 485 |
|